Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vestibular System in Migrainous Vertigo Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00901953
Recruitment Status : Unknown
Verified May 2009 by University of Bergen.
Recruitment status was:  Enrolling by invitation
First Posted : May 14, 2009
Last Update Posted : May 15, 2009
Sponsor:
Collaborator:
Sorlandet Hospital HF
Information provided by:
University of Bergen

Tracking Information
First Submitted Date May 12, 2009
First Posted Date May 14, 2009
Last Update Posted Date May 15, 2009
Study Start Date May 2007
Actual Primary Completion Date May 2009   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: May 12, 2009)
Differences in vestibular function [ Time Frame: Symptomfree interval ]
Original Primary Outcome Measures Same as current
Change History Complete list of historical versions of study NCT00901953 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures
 (submitted: May 12, 2009)
Differences in hypersensitivity [ Time Frame: Symptomfree interval ]
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Vestibular System in Migrainous Vertigo Patients
Official Title Do Migrainous Vertigo Patients Have More Hypersensitivity in Their Vestibular System Than Migraine Patients Without Vertigo?
Brief Summary

Do migrainous vertigo patients have more pathology in their vestibular system than migraine patients without vertigo?

The aim of this study is to compare the vestibular system of migraine patients with and without vertigo in the symptom-free period by vestibular function tests, videonystagmography, vestibular evoked myogenic potentials, and subjective visual vertical.

Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Case Control
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population

Migraine patients: primary care clinic

Migrainous vertigo patients: Neurological outpatients clinic, Sorlandet Hospital HF, Kristiansand and Spesialistsenteret, Tollbodgata 4, Kristiansand.

Condition
  • Migraine Disorders
  • Migraine Variant
  • Episodic Recurrent Vertigo
Intervention Not Provided
Study Groups/Cohorts
  • 1
    migrainous vertigo
  • 2
    migraine without vertigo
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: May 12, 2009)
65
Original Estimated Enrollment Same as current
Estimated Study Completion Date September 2009
Actual Primary Completion Date May 2009   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • migraine according to IHS criteria
  • migrainous vertigo according to the Neuhauser-criteria

Exclusion Criteria:

  • no history of other neurological, vestibular, opthalmologic and ENT disorders
  • no medications that could possibly influence test results
  • intact hearing measured by audiometry
  • pregnancy
Sex/Gender
Sexes Eligible for Study: All
Ages 16 Years to 61 Years   (Child, Adult)
Accepts Healthy Volunteers Yes
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Norway
Removed Location Countries  
 
Administrative Information
NCT Number NCT00901953
Other Study ID Numbers 2.2006.3376
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Marion Ingeborg Boldingh, Departement of Neurology, Sørlandet Hospital HF , Kristiansand, Norway
Study Sponsor University of Bergen
Collaborators Sorlandet Hospital HF
Investigators
Principal Investigator: Åse Mygland, PhD Institute of clinical medicine, university of Bergen, Norway
PRS Account University of Bergen
Verification Date May 2009